WallStreetZenWallStreetZen

NASDAQ: RLYB
Rallybio Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their RLYB stock forecasts and price targets.

Forecast return on equity

Is RLYB forecast to generate an efficient return?

Company
N/A
Industry
272.3%
Market
230.6%

Forecast return on assets

Is RLYB forecast to generate an efficient return on assets?

Company
N/A
Industry
93.94%

RLYB earnings per share forecast

What is RLYB's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.87
Avg 2 year Forecast
-$0.77
Avg 3 year Forecast
-$0.78

RLYB revenue forecast

What is RLYB's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$544.0k-19.29%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%

RLYB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RLYB$0.63N/AN/A
BTAI$1.83$26.67+1,357.21%Buy
PLUR$3.29$12.00+264.74%Strong Buy
NERV$3.71$4.00+7.82%Hold
IBIO$1.32$4.00+203.03%Strong Buy
View Top Biotech Stocks

Rallybio Stock Forecast FAQ

What is RLYB's earnings growth forecast for 2025-2027?

(NASDAQ: RLYB) Rallybio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 47.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.86%.

Rallybio's earnings in 2025 is -$14,170,000.On average, 6 Wall Street analysts forecast RLYB's earnings for 2025 to be -$36,625,352, with the lowest RLYB earnings forecast at -$37,259,009, and the highest RLYB earnings forecast at -$34,154,091. On average, 6 Wall Street analysts forecast RLYB's earnings for 2026 to be -$32,358,731, with the lowest RLYB earnings forecast at -$33,655,615, and the highest RLYB earnings forecast at -$28,387,816.

In 2027, RLYB is forecast to generate -$32,747,374 in earnings, with the lowest earnings forecast at -$31,463,163 and the highest earnings forecast at -$33,710,532.

If you're new to stock investing, here's how to buy Rallybio stock.

What is RLYB's revenue growth forecast for 2025-2027?

(NASDAQ: RLYB) Rallybio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 105.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.

Rallybio's revenue in 2025 is $674,000.On average, 5 Wall Street analysts forecast RLYB's revenue for 2025 to be $22,980,486, with the lowest RLYB revenue forecast at $16,559,559, and the highest RLYB revenue forecast at $35,484,770. On average, 4 Wall Street analysts forecast RLYB's revenue for 2026 to be $0, with the lowest RLYB revenue forecast at $0, and the highest RLYB revenue forecast at $0.

In 2027, RLYB is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is RLYB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RLYB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 93.94%.

What is RLYB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: RLYB) Rallybio's current Earnings Per Share (EPS) is -$0.32. On average, analysts forecast that RLYB's EPS will be -$0.87 for 2025, with the lowest EPS forecast at -$0.88, and the highest EPS forecast at -$0.81. On average, analysts forecast that RLYB's EPS will be -$0.77 for 2026, with the lowest EPS forecast at -$0.80, and the highest EPS forecast at -$0.67. In 2027, RLYB's EPS is forecast to hit -$0.78 (min: -$0.74, max: -$0.80).

What is RLYB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RLYB) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.